U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07382258) titled 'A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease' on Jan. 25.
Brief Summary: This clinical trial aims to assess the impact on exercise tolerance and the safety of inhaled nitric oxide in subjects with moderate-to-severe COPD. The findings are expected to contribute to the development of safe and effective therapeutic strategies for COPD management.
Study Start Date: May 17, 2023
Study Type: INTERVENTIONAL
Condition:
Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
DEVICE: Nitric Oxide Generation and Delivery System
A device designed to deliver a stable, user-prescribed c...